Truist Financial Corp Jasper Therapeutics, Inc. Transaction History

Truist Financial Corp

  • $62.9 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 22, 2022
SELL
$2.96 - $8.01 $33,300 - $90,112
-11,250 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$7.21 - $16.42 $81,112 - $184,725
11,250 New
11,250 $89,000

Others Institutions Holding JSPR

# of Institutions
1
Shares Held
5.63M
Call Options Held
0
Put Options Held
0
View Full List

About Jasper Therapeutics, Inc.

JSPR Quotes by TradingView
  • Ticker JSPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,073,300
  • Market Cap $821M
  • Description
  • Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a techniqu...
More about JSPR
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email